Ana Cespedes
Direttore/Membro del Consiglio presso ARGENX SE
Patrimonio netto: 84 396 $ in data 30/04/2024
Posizioni attive di Ana Cespedes
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARGENX SE | Direttore/Membro del Consiglio | 12/12/2022 | - |
Independent Dir/Board Member | 12/12/2022 | - | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Direttore operativo | - | - |
London School of Economics & Political Science | Corporate Officer/Principal | - | - |
Congreso de los Diputados | Corporate Officer/Principal | - | - |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
University of Navarra | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Ana Cespedes
Precedenti posizioni note di Ana Cespedes
Società | Posizione | Inizio | Fine |
---|---|---|---|
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Corporate Officer/Principal | - | - |
Merck KGAA Unsponsored ADR Facility | Vendite & Marketing | - | - |
Formazione di Ana Cespedes
Universidad Complutense de Madrid | Doctorate Degree |
University of Navarra | Masters Business Admin |
Statistiche
Distribuzione geografica
Spagna | 5 |
Stati Uniti | 4 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 7 |
Director/Board Member | 2 |
Chief Operating Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Government | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARGENX SE | Health Technology |
Aziende private | 5 |
---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Merck KGAA Unsponsored ADR Facility | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Health Technology |
Congreso de los Diputados | Government |
- Borsa valori
- Insiders
- Ana Cespedes
- Esperienza